MIVT.OTCBB
Current Price: US $0.22   Change: 0.00
Home Contact Us Careers Corporate Technology Trials Investors News Releases

Articles

May 13, 2008
Cardiovascular News International - VESTAsynce Polymer-Free DES shows promising results at nine months

May 8, 2008
Cardiac Interventions Today - MIV's VestaSync Polymer-Free DES Demonstrates Safety and Efficacy

May 1, 2008
Cardiovascular Business Magazine - MIV Therapeutics CEO discusses role of second-generation DES

April 18, 2008
Cardiovascular Business Magazine - Drug-eluting stents start their comeback  

April 16, 2008
Cardiovascular Business Magazine -  MIV presents positive preliminary data for its polymer-free DES  

April 10, 2008
Business Wire - MIV Therapeutics' First In-Man Study Data 'Very Encouraging', According To SISM Research Morning Note

April 8, 2008
Diagnostic and Interventional Cardiology - Human Study Demonstrates Safety Of Polymer-Free DES 

April 4, 2008
“First-In-Man” Study Demonstrates Safety of Polymer-Free Drug-Eluting Stents

April 3, 2008
Knobias ClipReport - CEO Discusses Positive Data from Trial of VESTAsync(TM) Drug-Eluting Stent

April 2, 2008
Medical Device Daily - New polymer-free DES, with 60% less drug, effective in patients

January 2008
2007 Investor Update

October 30 - November 5, 2007
Business In Vancouver - Stent makers scramble to stem corporate bleeding